Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jane F. Barlow currently holds 50,000 shares of Viracta Therapeutics, Inc. (VIRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jane F. Barlow has been a net buyer of VIRX stock. They have purchased $10.0K and sold $0 worth of shares.
Jane F. Barlow's most recent insider trade was on Jun 20, 2024, when they sold 50,000 shares at $0.00 per share.
Jane F. Barlow serves as Executive at Viracta Therapeutics, Inc. (VIRX). They have executed 4 insider transactions totaling $10.0K over their tenure at the company.
Jane F. Barlow holds the position of Executive at Viracta Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Jane F. Barlow has shown a buying trading pattern, with $10.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Jane F. Barlow was on Aug 12, 2019, when they purchased $10.0K worth of TXMD shares. This transaction involved 3,144 shares at $3.18 per share.
Jane F. Barlow currently owns 50,000 shares of Viracta Therapeutics, Inc. (VIRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jane F. Barlow's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jane F. Barlow has 4 Form 4 filings on record as an insider at Viracta Therapeutics, Inc..
Set alerts for Jane F. Barlow and 40,000+ other insiders.